565 studies found for:    Open Studies | "Liver Neoplasms"
Show Display Options
Rank Status Study
1 Recruiting PET/CT-Assessment of Liver Tumor Ablation
Conditions: Liver Tumor;   Liver Neoplasms
Interventions: Radiation: N-13 ammonia;   Device: PET/CT scanner
2 Recruiting Fusion Guided Thermal Ablation Combined With External Beam Radiation for Hepatic Neoplasms
Conditions: Liver Neoplasms;   Hepatic Cancer;   Liver Cancer
Interventions: Procedure: Thermal Ablation;   Procedure: Standard External Beam Radiation Therapy
3 Recruiting Sorafenib and TRC105 in Hepatocellular Cancer
Conditions: Hepatoma;   Liver Neoplasms;   Adenoma, Liver Cell;   Carcinoma, Hepatocellular;   Liver Neoplasms, Experimental
Interventions: Drug: TRC 105;   Drug: Sorafenib
4 Recruiting Dose Escalation Study of OMP-54F28 in Combination With Sorafenib in Patients With Hepatocellular Cancer
Conditions: Hepatocellular Cancer;   Liver Cancer
Intervention: Drug: OMP-54F28 with Sorafenib
5 Recruiting Follow-up Yttrium-90 Internal Pair Production PET/CT Imaging in Patients With Primary or Metastatic Liver Tumors as Compared With Brehmsstrahlung Imaging
Conditions: Liver Cancer;   Hepatic Tumors
Intervention: Device: PET/CT Scan
6 Unknown  Study of Hepatoma Treated by Perfusing Cinobufacin Through Hepatic Artery Combining Embolotherapy
Conditions: Hepatoma;   Cinobufacin Injection
Intervention: Drug: Cinobufacin injection
7 Unknown  Treatment of Unresectable Hepatocellular Cancer With Opioid Growth Factor
Condition: Hepatocellular Cancer
Intervention: Drug: [Met5]-enkephalin (Infusion of opioid growth factor )
8 Unknown  Stereotactic Body Radiation Therapy (SBRT) in the Treatment of Liver Tumors
Condition: Liver Tumors
Intervention: Radiation: Stereotactic Body Radiation Therapy
9 Recruiting Phase II Trial of Tivozanib in Advanced Hepatocellular Cancer
Condition: Hepatocellular Cancer
Intervention: Drug: Tivozanib
10 Recruiting Microwave Ablation of Resectable Liver Tumors
Conditions: Hepatocellular Carcinoma;   Liver Cancer
Intervention: Device: Microwave Ablation
11 Recruiting Lipiodol as an Imaging Biomarker in Patients With Primary and Metastatic Liver Cancer
Condition: Liver Cancer
Intervention: Drug: Lipiodol
12 Recruiting TheraSphere® for Treatment of Unresectable Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma;   Liver Cancer;   Liver Neoplasm;   Primary Liver Cancer
Intervention: Device: TheraSphere
13 Recruiting Transarterial Chemoembolization Using Doxorubicin Beads With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery
Condition: Liver Cancer
Interventions: Drug: doxorubicin-eluting beads;   Drug: sorafenib tosylate;   Other: laboratory biomarker analysis;   Other: pharmacogenomic studies;   Other: pharmacological study;   Procedure: quality-of-life assessment
14 Recruiting Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery
Conditions: Adult Primary Hepatocellular Carcinoma;   Adult Primary Undifferentiated Hepatocellular Carcinoma;   Advanced Adult Primary Liver Cancer;   Childhood Hepatocellular Carcinoma;   Localized Unresectable Adult Primary Liver Cancer;   Recurrent Adult Primary Liver Cancer;   Recurrent Childhood Liver Cancer;   Stage C Adult Primary Liver Cancer (BCLC);   Stage D Adult Primary Liver Cancer (BCLC);   Stage III Childhood Liver Cancer;   Stage IV Childhood Liver Cancer
Interventions: Drug: sorafenib tosylate;   Other: laboratory biomarker analysis
15 Recruiting 3-Tesla MRI Response to TACE in HCC (Liver Cancer)
Conditions: Adult Primary Hepatocellular Carcinoma;   Advanced Adult Primary Liver Cancer;   Localized Resectable Adult Primary Liver Cancer;   Localized Unresectable Adult Primary Liver Cancer;   Stage A Adult Primary Liver Cancer (BCLC);   Stage B Adult Primary Liver Cancer (BCLC)
Interventions: Device: 3 Tesla Magnetic Resonance Imaging;   Drug: Magnevist® (Intravenous (IV) administration of MRI contrast agent)
16 Recruiting Tivozanib in Treating Patients With Liver Cancer That is Metastatic or Cannot Be Removed by Surgery
Conditions: Adult Primary Hepatocellular Carcinoma;   Advanced Adult Primary Liver Cancer;   Localized Unresectable Adult Primary Liver Cancer;   Recurrent Adult Primary Liver Cancer;   Stage C Adult Primary Liver Cancer (BCLC);   Stage D Adult Primary Liver Cancer (BCLC)
Interventions: Drug: tivozanib;   Other: pharmacological study;   Other: laboratory biomarker analysis
17 Recruiting Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer
Conditions: Adult Primary Hepatocellular Carcinoma;   Advanced Adult Primary Liver Cancer;   Localized Unresectable Adult Primary Liver Cancer;   Recurrent Adult Primary Liver Cancer;   Stage C Adult Primary Liver Cancer (BCLC);   Stage D Adult Primary Liver Cancer (BCLC)
Interventions: Drug: doxorubicin hydrochloride;   Drug: sorafenib tosylate;   Other: laboratory biomarker analysis;   Other: pharmacological study
18 Recruiting Proton Beam Irradiation for the Treatment of Unresectable Hepatocellular Cancer and Cholangiocarcinoma
Condition: Liver Cancer
Intervention: Radiation: Proton Beam Irradiation
19 Recruiting Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer
Conditions: Childhood Hepatoblastoma;   Stage I Childhood Liver Cancer;   Stage II Childhood Liver Cancer;   Stage III Childhood Liver Cancer;   Stage IV Childhood Liver Cancer
Interventions: Procedure: therapeutic conventional surgery;   Drug: cisplatin;   Drug: fluorouracil;   Drug: vincristine sulfate;   Drug: doxorubicin hydrochloride;   Drug: irinotecan hydrochloride;   Drug: temsirolimus;   Procedure: liver transplantation;   Other: laboratory biomarker analysis
20 Recruiting Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Liver Cancer
Conditions: Childhood Hepatoblastoma;   Stage I Childhood Liver Cancer;   Stage II Childhood Liver Cancer;   Stage III Childhood Liver Cancer;   Stage IV Childhood Liver Cancer
Interventions: Procedure: therapeutic conventional surgery;   Drug: cisplatin;   Drug: fluorouracil;   Drug: vincristine sulfate;   Drug: doxorubicin hydrochloride;   Drug: irinotecan hydrochloride;   Procedure: liver transplantation;   Other: laboratory biomarker analysis

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years